Production (Stage)
Minerva Neurosciences, Inc.
NERV
$1.84
$0.052.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 16.85M | 19.65M | 20.15M | 20.25M | 18.28M |
| Gross Profit | -16.85M | -19.65M | -20.15M | -20.25M | -18.28M |
| SG&A Expenses | 9.98M | 9.95M | 9.86M | 10.02M | 10.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.07M | 21.85M | 24.50M | 26.21M | 24.45M |
| Operating Income | -19.07M | -21.85M | -24.50M | -26.21M | -24.45M |
| Income Before Tax | 6.25M | 1.44M | -3.31M | -33.65M | -31.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.25 | 1.44 | -3.31 | -33.65 | -31.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.25M | 1.44M | -3.31M | -33.65M | -31.60M |
| EBIT | -19.07M | -21.85M | -24.50M | -26.21M | -24.45M |
| EBITDA | -19.06M | -21.84M | -24.49M | -26.21M | -24.45M |
| EPS Basic | 0.83 | 0.19 | -0.44 | -4.45 | -4.48 |
| Normalized Basic EPS | 0.52 | 0.12 | -0.27 | -2.78 | -2.80 |
| EPS Diluted | 0.82 | 0.19 | -0.44 | -4.45 | -4.48 |
| Normalized Diluted EPS | 0.52 | 0.12 | -0.27 | -2.78 | -2.80 |
| Average Basic Shares Outstanding | 30.28M | 30.28M | 30.28M | 30.28M | 28.22M |
| Average Diluted Shares Outstanding | 30.28M | 30.28M | 30.28M | 30.28M | 28.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |